Aspire Bariatrics is a medical device company that is revolutionizing the treatment of obesity with its non-surgical weight loss system, the AspireAssist. The AspireAssist was FDA approved in the United States in June 2016 based on a Randomized Clinical Trial at 10 leading institutions across the United States, including Brigham & Women's, Mayo Clinic, Northwestern University, University of Pennsylvania, Weill Cornell, and Washington University in St. Louis. The clinical study showed excellent safety and best-in-class weight loss results among endoscopic weight loss procedures. The AspireAssist is also CE-marked and commercially available the European Union, Middle East, and New Zealand. Learn more at aspirebariatrics.com
AspireAssist Weight Loss Procedure Address
3200 Horizon Drive, Ste 100 King of Prussia, PA United States